The University of Kentucky Research Foundation was awarded a $2,988,630 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will fund the development of visual-motor coordination assessments and decision support tools to optimize return to duty for patients with chronic ankle instability from September 1, 2022 to August 31, 2026. The Military Medical Research and Development program supports basic,...
This $1,499,334 federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The grant, awarded to the University of Kentucky Research Foundation on June 15, 2025, will fund a 4-year research project to explore "NEW PARADIGMS IN ANKLE FRACTURE REHABILITATION". The research...
This $1,066,463 Department of Defense Military Medical Research and Development Program (CFDA 12.420) project grant, awarded on September 30, 2023, will support a 4-year study titled "REVEALING THE PROGRESSION OF PAIN PATHWAYS AND IDENTIFYING CHRONIFICATION OF PAIN PREDICTORS AFTER AN ISOLATED LATERAL ANKLE SPRAIN: PROJECT RECOIL". The prime grantee, the University of Kentucky Research Foundation, will collaborate with a sub-grantee, the Henry M. Jackson Foundation for the...
The Cooperative Agreement award, funded by the Uniformed Services University of the Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750), supports the NEUROCOGNITIVE ANKLE TRAINING FOR INSTABILITY TO OPTIMIZE NEUROMUSCULOSKELETAL OUTCOMES (NATION) project for chronic ankle instability. The $1,073,016.00 award, granted to the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., will fund a 3-year research initiative to...
The University of Kentucky Research Foundation was awarded a $1,442,152 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on the "RUCKING-RELATED ASSESSMENT OF MUSCULAR, PSYCHOLOGICAL AND BIOMECHANICAL CONTRIBUTORS TO HIP PAIN AND CARTILAGE INTEGRITY IN FEMALES (RAMP)" over the period of September 1, 2025 to August 31, 2028. This research grant aims to transform healthcare for military service members by...
The University of Kentucky Research Foundation has received a $2,061,903 Project Grant award from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct a 4-year research project titled "Novel Calcitropes as Targets for Cardiomyopathy Treatment". This award aims to support innovative biomedical research focused on developing new treatments for heart disease. The Research Foundation, a non-profit subsidiary of the University of...
The University of Kentucky Research Foundation has been awarded a $612,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) from the Defense Health Agency. The grant will fund the development of a new personalized medicine model for high-risk pediatric sarcomas, with a performance period from August 1, 2024 to July 31, 2026. As the prime awardee, the Research Foundation will leverage its expertise in biomedical research and collaborative partnerships to...
The University of Kentucky Research Foundation received a $1,377,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award, running from June 1, 2024 to May 31, 2027, supports research on PLK1 in prostate cancer lineage plasticity. As a non-profit subsidiary of the University of Kentucky, the Research Foundation facilitates the university's participation in federal grants and contracts by managing intellectual property...
The University of Kentucky Research Foundation was awarded a $954,307.97 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective May 1, 2025 through April 30, 2028, supports research to repurpose the drug ebselen for the treatment of traumatic brain injury-induced pathological tau protein activation in tauopathies and Alzheimer's disease. This advanced biomedical research project aims to transform healthcare for...
The University of Kentucky Research Foundation was awarded a $1,376,999 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) on September 15, 2022. The grant will fund the development of a highly selective MPGES-1 inhibitor as a non-opioid treatment for chronic pain through September 14, 2026. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...